Document Classification

Section Type: RESULTS

Text: The pharmacokinetic parameters of erythromycin propionate after taking erythromycin stinoprate capsules were as follows : Low dose group : Ka (2. 007 + / - 1. 281) / h, tmax (actual value) (1. 9 + / - 0. 6) h, Cmax (437. 0 + / - 295. 0) microg/L, AUC0-14 (trapezoid area) (1840. 2 + / - 1476. 87) microg x h/L, Ke (0. 329 + / - 0. 119) / h, T1/2 (2. 45 + / - 0. 9) h. Middle dose group : Ka (1. 451 + / - 0. 380) / h, tmax (1. 7 + / - 0. 3) h, Cmax (923. 1 + / - 217. 5) microg/L, AUC0-14 (4542. 44 + / - 1579. 4) microg x h/L, Ke (0. 237 + / - 0. 057) / h, T1/2 (3. 1 + / - 1. 1) h ; High dose group : Ka (2. 076 + / - 1. 559) / h, tmax (1. 7 + / - 0. 3) h, Cmax (1336. 5 + / - 366. 0) microg/L, AUC0-14 (7481. 5 + / - 2496. 2) microg x h/L, Ke (0. 266 + / - 0. 051) / h, T1/2 (2. 7 + / - 0. 5) h.